Baclofen (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Baclofen" in English language version.

refsWebsite

Global rank English rank

45nih.gov

4^th place

25doi.org

2^nd place

8semanticscholar.org

11^th place

8^th place

4web.archive.org

1^st place

3drugs.com

399^th place

333^rd place

2medscape.com

719^th place

636^th place

2clincalc.com

3,912^th place

2,496^th place

2fda.gov

447^th place

338^th place

1canada.ca

1,712^th place

1,063^rd place

1uspharmacist.com

low place

1nhs.uk

1,989^th place

1,528^th place

1mhmedical.com

6,846^th place

4,957^th place

1nice.org.uk

3,258^th place

2,666^th place

1tga.gov.au

3,984^th place

2,622^nd place

1books.google.com

3^rd place

1bentham.org

low place

1harvard.edu

18^th place

17^th place

1uva.nl

3,518^th place

2,652^nd place

1handle.net

102^nd place

76^th place

1washington.edu

1,067^th place

749^th place

1sante.fr

8,603^rd place

low place

1destinationsante.com

low place

bentham.org

Yogeeswari P, Ragavendran JV, Sriram D (January 2006). "An update on GABA analogs for CNS drug discovery" (PDF). Recent Patents on CNS Drug Discovery. 1 (1): 113–118. doi:10.2174/157488906775245291. PMID 18221197. Archived from the original (PDF) on 16 June 2010.

books.google.com

Froestl W (2010). "Chemistry and Pharmacology of GABAb Receptor Ligands". In Blackburn TP (ed.). GABAb Receptor Pharmacology – A Tribute to Norman Bowery. Advances in Pharmacology. Vol. 58. pp. 19–62. doi:10.1016/S1054-3589(10)58002-5. ISBN 978-0-12-378647-0. PMID 20655477.

canada.ca

"Product monograph brand safety updates". Health Canada. 6 June 2024. Retrieved 8 June 2024.

clincalc.com

"The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
"Baclofen - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.

destinationsante.com

"Autorisation du baclofène: des conditions d'utilisation trop restrictives ? - A la une" [Authorization of baclofen: too restrictive conditions of use? - Featured]. L'Agence nationale de sécurité du médicament et des produits de santé (ANSM) [The National Agency for the Safety of Medicines and Health Products] (in French). 25 October 2018. Archived from the original on 25 October 2018.

doi.org

Agabio R, Saulle R, Rösner S, Minozzi S (January 2023). "Baclofen for alcohol use disorder". The Cochrane Database of Systematic Reviews. 1 (1): CD012557. doi:10.1002/14651858.cd012557.pub3. PMC 9837849. PMID 36637087.
Ahmadi-Abhari SA, Akhondzadeh S, Assadi SM, Shabestari OL, Farzanehgan ZM, Kamlipour A (February 2001). "Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial". Journal of Clinical Pharmacy and Therapeutics. 26 (1): 67–71. doi:10.1111/j.1365-2710.2001.00325.x. PMID 11286609. S2CID 28295723.
Assadi SM, Radgoodarzi R, Ahmadi-Abhari SA (November 2003). "Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]". BMC Psychiatry. 3: 16. doi:10.1186/1471-244X-3-16. PMC 293465. PMID 14624703.
Vreugdenhil S, Weidenaar AC, de Jong IJ, van Driel MF (December 2017). "Sleep-Related Painful Erections-A Case Series of 24 Patients Regarding Diagnostics and Treatment Options". Sexual Medicine. 5 (4): e237–e243. doi:10.1016/j.esxm.2017.09.001. PMC 5693397. PMID 29066083.
Grenier B, Mesli A, Cales J, Castel JP, Maurette P (1996). "[Severe hyperthermia caused by sudden withdrawal of continuous intrathecal administration of baclofen]". Annales Françaises d'Anesthésie et de Réanimation. 15 (5): 659–662. doi:10.1016/0750-7658(96)82130-7. PMID 9033759.
Leo RJ, Baer D (November–December 2005). "Delirium associated with baclofen withdrawal: a review of common presentations and management strategies". Psychosomatics. 46 (6): 503–507. doi:10.1176/appi.psy.46.6.503. PMID 16288128.
Leggio L, Garbutt JC, Addolorato G (March 2010). "Effectiveness and safety of baclofen in the treatment of alcohol dependent patients". CNS & Neurological Disorders Drug Targets. 9 (1): 33–44. doi:10.2174/187152710790966614. PMID 20201813.
Agabio R, Preti A, Gessa GL (2013). "Efficacy and tolerability of baclofen in substance use disorders: a systematic review". European Addiction Research. 19 (6): 325–345. doi:10.1159/000347055. PMID 23775042. S2CID 1315087.
van Nieuwenhuijzen PS, McGregor IS, Hunt GE (January 2009). "The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen". Neuroscience. 158 (2): 441–455. doi:10.1016/j.neuroscience.2008.10.011. PMID 18996447. S2CID 22701676.
Murphy L, Wolfer H, Hendrickson RG (June 2021). "Toxicologic Confounders of Brain Death Determination: A Narrative Review". Neurocritical Care. 34 (3): 1072–1089. doi:10.1007/s12028-020-01114-y. PMC 7526708. PMID 33000377.
Perry HE, Wright RO, Shannon MW, Woolf AD (June 1998). "Baclofen overdose: drug experimentation in a group of adolescents". Pediatrics. 101 (6): 1045–1048. doi:10.1542/peds.101.6.1045. PMID 9606233.
Carter LP, Koek W, France CP (January 2009). "Behavioral analyses of GHB: receptor mechanisms". Pharmacology & Therapeutics. 121 (1): 100–114. doi:10.1016/j.pharmthera.2008.10.003. PMC 2631377. PMID 19010351.
Durant CF, Paterson LM, Turton S, Wilson SJ, Myers JF, Muthukumaraswamy S, et al. (14 December 2018). "Using Baclofen to Explore GABA-B Receptor Function in Alcohol Dependence: Insights From Pharmacokinetic and Pharmacodynamic Measures". Frontiers in Psychiatry. 9: 664. doi:10.3389/fpsyt.2018.00664. PMC 6302106. PMID 30618857.
Zvejniece L, Vavers E, Svalbe B, Veinberg G, Rizhanova K, Liepins V, et al. (October 2015). "R-phenibut binds to the α2-δ subunit of voltage-dependent calcium channels and exerts gabapentin-like anti-nociceptive effects". Pharmacology, Biochemistry, and Behavior. 137: 23–29. doi:10.1016/j.pbb.2015.07.014. PMID 26234470. S2CID 42606053.
Wuis EW, Dirks MJ, Termond EF, Vree TB, Van der Kleijn E (1989). "Plasma and urinary excretion kinetics of oral baclofen in healthy subjects". European Journal of Clinical Pharmacology. 37 (2): 181–184. doi:10.1007/BF00558228. PMID 2792173. S2CID 23828250.
Froestl W (2010). "Chemistry and Pharmacology of GABAb Receptor Ligands". In Blackburn TP (ed.). GABAb Receptor Pharmacology – A Tribute to Norman Bowery. Advances in Pharmacology. Vol. 58. pp. 19–62. doi:10.1016/S1054-3589(10)58002-5. ISBN 978-0-12-378647-0. PMID 20655477.
Yogeeswari P, Ragavendran JV, Sriram D (January 2006). "An update on GABA analogs for CNS drug discovery" (PDF). Recent Patents on CNS Drug Discovery. 1 (1): 113–118. doi:10.2174/157488906775245291. PMID 18221197. Archived from the original (PDF) on 16 June 2010.
Romito JW, Turner ER, Rosener JA, Coldiron L, Udipi A, Nohrn L, et al. (2021). "Baclofen therapeutics, toxicity, and withdrawal: A narrative review". SAGE Open Medicine. 9: 20503121211022197. doi:10.1177/20503121211022197. PMC 8182184. PMID 34158937.
Enserink M (May 2011). "Addiction research. Anonymous alcoholic bankrolls trial of controversial therapy". Science. 332 (6030): 653. Bibcode:2011Sci...332..653E. doi:10.1126/science.332.6030.653. PMID 21551041.
Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, et al. (December 2016). "Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial". European Neuropsychopharmacology. 26 (12): 1950–1959. doi:10.1016/j.euroneuro.2016.10.006. hdl:11245.1/cbb8e3d3-f5a2-4c1a-9e6d-f78c44e3cedb. PMID 27842939. S2CID 26005283.
Krach LE (October 2009). "Intrathecal baclofen use in adults with cerebral palsy". Developmental Medicine and Child Neurology. 51 (Suppl 4): 106–12. doi:10.1111/j.1469-8749.2009.03422.x. PMID 19740217. S2CID 20049367.
Liu J, Wang LN (November 2019). "Baclofen for alcohol withdrawal". The Cochrane Database of Systematic Reviews. 2019 (11). doi:10.1002/14651858.CD008502.pub6. PMC 6831488. PMID 31689723.
Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, et al. (December 2014). "An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A". Orphanet Journal of Rare Diseases. 9 (1): 199. doi:10.1186/s13023-014-0199-0. PMC 4311411. PMID 25519680.
Walker P, Watanabe S, Bruera E (August 1998). "Baclofen, a treatment for chronic hiccup". Journal of Pain and Symptom Management. 16 (2): 125–132. doi:10.1016/S0885-3924(98)00039-6. PMID 9737104.
Reynolds K, Kaufman R, Korenoski A, Fennimore L, Shulman J, Lynch M (July 2020). "Trends in gabapentin and baclofen exposures reported to U.S. poison centers". Clinical Toxicology. 58 (7): 763–772. doi:10.1080/15563650.2019.1687902. PMID 31786961. S2CID 208537638.

drugs.com

"Baclofen Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 3 March 2019.
"Baclofen Pregnancy and Breastfeeding Warnings". Drugs.com. Retrieved 3 March 2019.
"Baclofen". The American Society of Health-System Pharmacists. Retrieved 6 December 2011.

fda.gov

nctr-crs.fda.gov

"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.

fda.gov

"Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). 29 June 2023. Archived from the original on 29 June 2023. Retrieved 29 June 2023.

handle.net

hdl.handle.net

Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, et al. (December 2016). "Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial". European Neuropsychopharmacology. 26 (12): 1950–1959. doi:10.1016/j.euroneuro.2016.10.006. hdl:11245.1/cbb8e3d3-f5a2-4c1a-9e6d-f78c44e3cedb. PMID 27842939. S2CID 26005283.

harvard.edu

ui.adsabs.harvard.edu

Enserink M (May 2011). "Addiction research. Anonymous alcoholic bankrolls trial of controversial therapy". Science. 332 (6030): 653. Bibcode:2011Sci...332..653E. doi:10.1126/science.332.6030.653. PMID 21551041.

medscape.com

"Seizures Following High-Dose Baclofen With Alcohol". Medscape. Retrieved 24 March 2024.
"What Is the Latest on Treatment for Hiccups?". Medscape. Retrieved 29 July 2018.

mhmedical.com

accessmedicine.mhmedical.com

Siu G (2014). "Pharmacotherapy". In Maitin IB, Cruz E (eds.). CURRENT Diagnosis & Treatment: Physical Medicine & Rehabilitation. McGraw Hill. ISBN 978-0-07-179329-2.

nhs.uk

"Common questions about baclofen". nhs.uk. 3 March 2022. Retrieved 24 March 2024.

nice.org.uk

"BNF is only available in the UK". NICE. Retrieved 16 April 2019.

nih.gov

pubmed.ncbi.nlm.nih.gov

Agabio R, Saulle R, Rösner S, Minozzi S (January 2023). "Baclofen for alcohol use disorder". The Cochrane Database of Systematic Reviews. 1 (1): CD012557. doi:10.1002/14651858.cd012557.pub3. PMC 9837849. PMID 36637087.
Ahmadi-Abhari SA, Akhondzadeh S, Assadi SM, Shabestari OL, Farzanehgan ZM, Kamlipour A (February 2001). "Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial". Journal of Clinical Pharmacy and Therapeutics. 26 (1): 67–71. doi:10.1111/j.1365-2710.2001.00325.x. PMID 11286609. S2CID 28295723.
Assadi SM, Radgoodarzi R, Ahmadi-Abhari SA (November 2003). "Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]". BMC Psychiatry. 3: 16. doi:10.1186/1471-244X-3-16. PMC 293465. PMID 14624703.
Ghanavatian S, Derian A (May 2022). "Baclofen". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID 30252293.
Vreugdenhil S, Weidenaar AC, de Jong IJ, van Driel MF (December 2017). "Sleep-Related Painful Erections-A Case Series of 24 Patients Regarding Diagnostics and Treatment Options". Sexual Medicine. 5 (4): e237–e243. doi:10.1016/j.esxm.2017.09.001. PMC 5693397. PMID 29066083.
Grenier B, Mesli A, Cales J, Castel JP, Maurette P (1996). "[Severe hyperthermia caused by sudden withdrawal of continuous intrathecal administration of baclofen]". Annales Françaises d'Anesthésie et de Réanimation. 15 (5): 659–662. doi:10.1016/0750-7658(96)82130-7. PMID 9033759.
Leo RJ, Baer D (November–December 2005). "Delirium associated with baclofen withdrawal: a review of common presentations and management strategies". Psychosomatics. 46 (6): 503–507. doi:10.1176/appi.psy.46.6.503. PMID 16288128.
Leggio L, Garbutt JC, Addolorato G (March 2010). "Effectiveness and safety of baclofen in the treatment of alcohol dependent patients". CNS & Neurological Disorders Drug Targets. 9 (1): 33–44. doi:10.2174/187152710790966614. PMID 20201813.
Agabio R, Preti A, Gessa GL (2013). "Efficacy and tolerability of baclofen in substance use disorders: a systematic review". European Addiction Research. 19 (6): 325–345. doi:10.1159/000347055. PMID 23775042. S2CID 1315087.
van Nieuwenhuijzen PS, McGregor IS, Hunt GE (January 2009). "The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen". Neuroscience. 158 (2): 441–455. doi:10.1016/j.neuroscience.2008.10.011. PMID 18996447. S2CID 22701676.
Murphy L, Wolfer H, Hendrickson RG (June 2021). "Toxicologic Confounders of Brain Death Determination: A Narrative Review". Neurocritical Care. 34 (3): 1072–1089. doi:10.1007/s12028-020-01114-y. PMC 7526708. PMID 33000377.
Perry HE, Wright RO, Shannon MW, Woolf AD (June 1998). "Baclofen overdose: drug experimentation in a group of adolescents". Pediatrics. 101 (6): 1045–1048. doi:10.1542/peds.101.6.1045. PMID 9606233.
Carter LP, Koek W, France CP (January 2009). "Behavioral analyses of GHB: receptor mechanisms". Pharmacology & Therapeutics. 121 (1): 100–114. doi:10.1016/j.pharmthera.2008.10.003. PMC 2631377. PMID 19010351.
Durant CF, Paterson LM, Turton S, Wilson SJ, Myers JF, Muthukumaraswamy S, et al. (14 December 2018). "Using Baclofen to Explore GABA-B Receptor Function in Alcohol Dependence: Insights From Pharmacokinetic and Pharmacodynamic Measures". Frontiers in Psychiatry. 9: 664. doi:10.3389/fpsyt.2018.00664. PMC 6302106. PMID 30618857.
Zvejniece L, Vavers E, Svalbe B, Veinberg G, Rizhanova K, Liepins V, et al. (October 2015). "R-phenibut binds to the α2-δ subunit of voltage-dependent calcium channels and exerts gabapentin-like anti-nociceptive effects". Pharmacology, Biochemistry, and Behavior. 137: 23–29. doi:10.1016/j.pbb.2015.07.014. PMID 26234470. S2CID 42606053.
Wuis EW, Dirks MJ, Termond EF, Vree TB, Van der Kleijn E (1989). "Plasma and urinary excretion kinetics of oral baclofen in healthy subjects". European Journal of Clinical Pharmacology. 37 (2): 181–184. doi:10.1007/BF00558228. PMID 2792173. S2CID 23828250.
Froestl W (2010). "Chemistry and Pharmacology of GABAb Receptor Ligands". In Blackburn TP (ed.). GABAb Receptor Pharmacology – A Tribute to Norman Bowery. Advances in Pharmacology. Vol. 58. pp. 19–62. doi:10.1016/S1054-3589(10)58002-5. ISBN 978-0-12-378647-0. PMID 20655477.
Yogeeswari P, Ragavendran JV, Sriram D (January 2006). "An update on GABA analogs for CNS drug discovery" (PDF). Recent Patents on CNS Drug Discovery. 1 (1): 113–118. doi:10.2174/157488906775245291. PMID 18221197. Archived from the original (PDF) on 16 June 2010.
Romito JW, Turner ER, Rosener JA, Coldiron L, Udipi A, Nohrn L, et al. (2021). "Baclofen therapeutics, toxicity, and withdrawal: A narrative review". SAGE Open Medicine. 9: 20503121211022197. doi:10.1177/20503121211022197. PMC 8182184. PMID 34158937.
Ochs GA (April 1993). "Intrathecal baclofen". Baillière's Clinical Neurology. 2 (1): 73–86. PMID 8143075.
Sallerin B, Lazorthes Y (May 2003). "[Intrathecal baclofen. Experimental and pharmacokinetic studies]". Neuro-Chirurgie (in French). 49 (2-3 Pt 2): 271–5. PMID 12746702.
Enserink M (May 2011). "Addiction research. Anonymous alcoholic bankrolls trial of controversial therapy". Science. 332 (6030): 653. Bibcode:2011Sci...332..653E. doi:10.1126/science.332.6030.653. PMID 21551041.
Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, et al. (December 2016). "Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial". European Neuropsychopharmacology. 26 (12): 1950–1959. doi:10.1016/j.euroneuro.2016.10.006. hdl:11245.1/cbb8e3d3-f5a2-4c1a-9e6d-f78c44e3cedb. PMID 27842939. S2CID 26005283.
Krach LE (October 2009). "Intrathecal baclofen use in adults with cerebral palsy". Developmental Medicine and Child Neurology. 51 (Suppl 4): 106–12. doi:10.1111/j.1469-8749.2009.03422.x. PMID 19740217. S2CID 20049367.
Liu J, Wang LN (November 2019). "Baclofen for alcohol withdrawal". The Cochrane Database of Systematic Reviews. 2019 (11). doi:10.1002/14651858.CD008502.pub6. PMC 6831488. PMID 31689723.
Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, et al. (December 2014). "An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A". Orphanet Journal of Rare Diseases. 9 (1): 199. doi:10.1186/s13023-014-0199-0. PMC 4311411. PMID 25519680.
Kampman KM (December 2005). "New medications for the treatment of cocaine dependence". Psychiatry. 2 (12): 44–48. PMC 2994240. PMID 21120115.
Walker P, Watanabe S, Bruera E (August 1998). "Baclofen, a treatment for chronic hiccup". Journal of Pain and Symptom Management. 16 (2): 125–132. doi:10.1016/S0885-3924(98)00039-6. PMID 9737104.
Reynolds K, Kaufman R, Korenoski A, Fennimore L, Shulman J, Lynch M (July 2020). "Trends in gabapentin and baclofen exposures reported to U.S. poison centers". Clinical Toxicology. 58 (7): 763–772. doi:10.1080/15563650.2019.1687902. PMID 31786961. S2CID 208537638.

ncbi.nlm.nih.gov

Agabio R, Saulle R, Rösner S, Minozzi S (January 2023). "Baclofen for alcohol use disorder". The Cochrane Database of Systematic Reviews. 1 (1): CD012557. doi:10.1002/14651858.cd012557.pub3. PMC 9837849. PMID 36637087.
Assadi SM, Radgoodarzi R, Ahmadi-Abhari SA (November 2003). "Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]". BMC Psychiatry. 3: 16. doi:10.1186/1471-244X-3-16. PMC 293465. PMID 14624703.
Ghanavatian S, Derian A (May 2022). "Baclofen". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID 30252293.
Vreugdenhil S, Weidenaar AC, de Jong IJ, van Driel MF (December 2017). "Sleep-Related Painful Erections-A Case Series of 24 Patients Regarding Diagnostics and Treatment Options". Sexual Medicine. 5 (4): e237–e243. doi:10.1016/j.esxm.2017.09.001. PMC 5693397. PMID 29066083.
Murphy L, Wolfer H, Hendrickson RG (June 2021). "Toxicologic Confounders of Brain Death Determination: A Narrative Review". Neurocritical Care. 34 (3): 1072–1089. doi:10.1007/s12028-020-01114-y. PMC 7526708. PMID 33000377.
Carter LP, Koek W, France CP (January 2009). "Behavioral analyses of GHB: receptor mechanisms". Pharmacology & Therapeutics. 121 (1): 100–114. doi:10.1016/j.pharmthera.2008.10.003. PMC 2631377. PMID 19010351.
Durant CF, Paterson LM, Turton S, Wilson SJ, Myers JF, Muthukumaraswamy S, et al. (14 December 2018). "Using Baclofen to Explore GABA-B Receptor Function in Alcohol Dependence: Insights From Pharmacokinetic and Pharmacodynamic Measures". Frontiers in Psychiatry. 9: 664. doi:10.3389/fpsyt.2018.00664. PMC 6302106. PMID 30618857.
Romito JW, Turner ER, Rosener JA, Coldiron L, Udipi A, Nohrn L, et al. (2021). "Baclofen therapeutics, toxicity, and withdrawal: A narrative review". SAGE Open Medicine. 9: 20503121211022197. doi:10.1177/20503121211022197. PMC 8182184. PMID 34158937.
Liu J, Wang LN (November 2019). "Baclofen for alcohol withdrawal". The Cochrane Database of Systematic Reviews. 2019 (11). doi:10.1002/14651858.CD008502.pub6. PMC 6831488. PMID 31689723.
Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, et al. (December 2014). "An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A". Orphanet Journal of Rare Diseases. 9 (1): 199. doi:10.1186/s13023-014-0199-0. PMC 4311411. PMID 25519680.
Kampman KM (December 2005). "New medications for the treatment of cocaine dependence". Psychiatry. 2 (12): 44–48. PMC 2994240. PMID 21120115.

dailymed.nlm.nih.gov

"Gablofen- baclofen injection injection, solution". DailyMed. Retrieved 7 November 2021.
"Lioresal- baclofen injection". DailyMed. Retrieved 7 November 2021.
"Ozobax- baclofen solution". DailyMed. Retrieved 7 November 2021.
"Lyvispah- baclofen granule". DailyMed. Retrieved 19 December 2021.
"Fleqsuvy- baclofen suspension". DailyMed. 4 February 2022. Retrieved 16 March 2022.

sante.fr

ansm.sante.fr

"Une recommandation temporaire d'utilisation (RTU) est accordée pour le baclofène – Point d'information" [A temporary recommendation for use (RTU) is granted for baclofen – Information point]. L'Agence nationale de sécurité du médicament et des produits de santé (ANSM) [The National Agency for the Safety of Medicines and Health Products]. 14 March 2014.

semanticscholar.org

api.semanticscholar.org

Ahmadi-Abhari SA, Akhondzadeh S, Assadi SM, Shabestari OL, Farzanehgan ZM, Kamlipour A (February 2001). "Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial". Journal of Clinical Pharmacy and Therapeutics. 26 (1): 67–71. doi:10.1111/j.1365-2710.2001.00325.x. PMID 11286609. S2CID 28295723.
Agabio R, Preti A, Gessa GL (2013). "Efficacy and tolerability of baclofen in substance use disorders: a systematic review". European Addiction Research. 19 (6): 325–345. doi:10.1159/000347055. PMID 23775042. S2CID 1315087.
van Nieuwenhuijzen PS, McGregor IS, Hunt GE (January 2009). "The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen". Neuroscience. 158 (2): 441–455. doi:10.1016/j.neuroscience.2008.10.011. PMID 18996447. S2CID 22701676.
Zvejniece L, Vavers E, Svalbe B, Veinberg G, Rizhanova K, Liepins V, et al. (October 2015). "R-phenibut binds to the α2-δ subunit of voltage-dependent calcium channels and exerts gabapentin-like anti-nociceptive effects". Pharmacology, Biochemistry, and Behavior. 137: 23–29. doi:10.1016/j.pbb.2015.07.014. PMID 26234470. S2CID 42606053.
Wuis EW, Dirks MJ, Termond EF, Vree TB, Van der Kleijn E (1989). "Plasma and urinary excretion kinetics of oral baclofen in healthy subjects". European Journal of Clinical Pharmacology. 37 (2): 181–184. doi:10.1007/BF00558228. PMID 2792173. S2CID 23828250.
Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, et al. (December 2016). "Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial". European Neuropsychopharmacology. 26 (12): 1950–1959. doi:10.1016/j.euroneuro.2016.10.006. hdl:11245.1/cbb8e3d3-f5a2-4c1a-9e6d-f78c44e3cedb. PMID 27842939. S2CID 26005283.
Krach LE (October 2009). "Intrathecal baclofen use in adults with cerebral palsy". Developmental Medicine and Child Neurology. 51 (Suppl 4): 106–12. doi:10.1111/j.1469-8749.2009.03422.x. PMID 19740217. S2CID 20049367.
Reynolds K, Kaufman R, Korenoski A, Fennimore L, Shulman J, Lynch M (July 2020). "Trends in gabapentin and baclofen exposures reported to U.S. poison centers". Clinical Toxicology. 58 (7): 763–772. doi:10.1080/15563650.2019.1687902. PMID 31786961. S2CID 208537638.

tga.gov.au

ebs.tga.gov.au

"Product Information Clofen". TGA eBusiness Services. Millers Point, Australia: Alphapharm Pty Limited. 7 June 2017. Retrieved 15 August 2017.

uspharmacist.com

Allen Jr LV (17 November 2010). "Baclofen 2%, Gabapentin 6%, and Clonidine Hydrochloride 0.1% in Pluronic Lecithin Organogel". U.S. Pharmacist. Jobson Medical Information LLC. Retrieved 9 August 2023.

uva.nl

dare.uva.nl

Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, et al. (December 2016). "Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial". European Neuropsychopharmacology. 26 (12): 1950–1959. doi:10.1016/j.euroneuro.2016.10.006. hdl:11245.1/cbb8e3d3-f5a2-4c1a-9e6d-f78c44e3cedb. PMID 27842939. S2CID 26005283.

washington.edu

sci.washington.edu

"Intrathecal Baclofen Therapy for Spasticity". Northwest Regional Spinal Cord Injury System. University of Washington. Retrieved 21 March 2024.

web.archive.org

"Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). 29 June 2023. Archived from the original on 29 June 2023. Retrieved 29 June 2023.
"The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
Yogeeswari P, Ragavendran JV, Sriram D (January 2006). "An update on GABA analogs for CNS drug discovery" (PDF). Recent Patents on CNS Drug Discovery. 1 (1): 113–118. doi:10.2174/157488906775245291. PMID 18221197. Archived from the original (PDF) on 16 June 2010.
"Autorisation du baclofène: des conditions d'utilisation trop restrictives ? - A la une" [Authorization of baclofen: too restrictive conditions of use? - Featured]. L'Agence nationale de sécurité du médicament et des produits de santé (ANSM) [The National Agency for the Safety of Medicines and Health Products] (in French). 25 October 2018. Archived from the original on 25 October 2018.